Insurance Solutions
Mergers & acquisitions
Loading component...
Loading component...
Overview
We’re set to see in 2023 the fewest non-life Part VII transfers sanctioned by the UK since the early 2000s. What does the future hold for the strategy?
In 2022, life and health insurance transaction activity was down sharply. Our research points to the likely causes and projects the landscape for future mergers and acquisitions.
Success in mergers and acquisitions (M&A) often requires the potential acquirer to identify opportunities to increase the value of the target.
We review the M&A worldwide for life and health insurers in 2021, and an outlook for 2022 and beyond.
Topics include an update on Part VII transfers and schemes of arrangement and an update on M&A activity in Europe.
A significant benefit of a cyber risk assessment during M&A due diligence is that it presents the broadest view of how to value the cyber risk of a target company, while at the same time taking into account that company's current insurance protections.
In this article, we illustrate the sorts of analyses which are possible by looking at a sample of 24 transactions in Europe over the last couple of years across a wide range of EU markets.
The Solvency II Appraisal Value (SII-AV) provides a workable methodology for use in M&A transactions, which is aligned with the way that investors generally view potential target companies.
